aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
viernes, 16 de septiembre de 2022
NCTR Research Highlights | FDA
NCTR Research Highlights | FDA
FDA NanoDay Symposium 2022 — Register for the Free Event
The Center for Drug Evaluation and Research’s Small Business and Industry Assistance (CDER SBIA) group will host the FDA NanoDay Symposium 2022 on October 11th from 8:50 AM to 3:10 PM EASTERN. This event is free to the public, but registration is required.
Dr. Anil Patri, NCTR Nanocore Director and chair of the FDA Nanotechnology Task Force, will present the welcome message and discuss nanomaterial standards development at FDA. Dr. Patri will also participate in the Question & Answer panel at the end of the symposium.
For event information, including the agenda and virtual attendance, please visit FDA NanoDay Symposium 2022.
No hay comentarios:
Publicar un comentario